DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1Dr.Reddy's Laboratories Limited
02 1Apicore Pharmaceuticals Private Limited
03 1Aptuit (Oxford) Ltd
04 1Hetero Labs Limited
05 1MSN Laboratories Private Limited
06 1Sionc Pharmaceutical Private Limited
Reset all filters
01 3PLERIXAFOR
02 3Plerixafor
Reset all filters
01 1Germany
02 5India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-954
Start Marketing Date : 2012-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-202
Start Marketing Date : 2017-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71924-0063
Start Marketing Date : 2019-08-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0067
Start Marketing Date : 2008-12-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0050
Start Marketing Date : 2016-08-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0017
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
16
PharmaCompass offers a list of Plerixafor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Plerixafor manufacturer or Plerixafor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Plerixafor manufacturer or Plerixafor supplier.
PharmaCompass also assists you with knowing the Plerixafor API Price utilized in the formulation of products. Plerixafor API Price is not always fixed or binding as the Plerixafor Price is obtained through a variety of data sources. The Plerixafor Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Plerixafor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Plerixafor, including repackagers and relabelers. The FDA regulates Plerixafor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Plerixafor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Plerixafor manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Plerixafor supplier is an individual or a company that provides Plerixafor active pharmaceutical ingredient (API) or Plerixafor finished formulations upon request. The Plerixafor suppliers may include Plerixafor API manufacturers, exporters, distributors and traders.
click here to find a list of Plerixafor suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Plerixafor as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Plerixafor API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Plerixafor as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Plerixafor and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Plerixafor NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Plerixafor suppliers with NDC on PharmaCompass.
We have 6 companies offering Plerixafor
Get in contact with the supplier of your choice: